Solace Lifesciences, Inc.

nucalm is a revolutionary technology proven to remediate chronic stress at the midbrain level. the nucalm system uses 4 components to provide a biological mimic of the same neural pathways the body uses to enter the first stage of sleep. this serves to 'turn off' the hypothalamic-pituitary-adrenal axis and puts the body in a parasympathetic dominant state within minutes without drugs. after 8 years of development and clinical testing under the direction of its inventor dr. g. blake holloway, nucalm was made commercially available in september, 2010. over 120,000 people have used nucalm in medical and dental procedures without a single reported negative event. 570 nucalm systems are currently in use by healthcare professionals, executives, and athletes in 44 states, canada, the u.k. and australia. initially released in the dental industry to reduce dental anxiety without drugs, nucalm has since found successful applications in cardiology, oncology, addiction recovery, sleep medicine, ea